APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug Metabolism and Pharmacokinetics (DMPK) Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Outlook and Growth Opportunities 2026

3 May 2026197 pages

Choose your research edition.

Industry ResearchDrug Metabolism and Pharmacokinetics (DMPK) Service Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Metabolism and Pharmacokinetics (DMPK) Service Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Drug Metabolism and Pharmacokinetics (DMPK) Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Metabolism and Pharmacokinetics (DMPK) Service Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Metabolism and Pharmacokinetics (DMPK) Service Market Analysis and Forecast 2026-2032184 pages · $4,950 USD

Market perspective

The global Drug Metabolism and Pharmacokinetics (DMPK) Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Drug Metabolism and Pharmacokinetics (DMPK) Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Drug Metabolism and Pharmacokinetics (DMPK) Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drug Metabolism and Pharmacokinetics (DMPK) Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Drug Metabolism and Pharmacokinetics (DMPK) Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Drug Metabolism and Pharmacokinetics (DMPK) Service market include NuChem Sciences Inc, Sygnature Discovery, Paraza Pharma, Inc, Dalriada, Inotiv, Eurofins Discovery, RTI International, Frontage Labs and Labcorp, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Drug Metabolism and Pharmacokinetics (DMPK) Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drug Metabolism and Pharmacokinetics (DMPK) Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drug Metabolism and Pharmacokinetics (DMPK) Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Drug Metabolism and Pharmacokinetics (DMPK) Service market.

Drug Metabolism and Pharmacokinetics (DMPK) Service Segment by Company

NuChem Sciences Inc

Sygnature Discovery

Paraza Pharma, Inc

Dalriada

Inotiv

Eurofins Discovery

RTI International

Frontage Labs

Labcorp

Jubilant Biosys

Creative Biolabs

Evotec

Charles River

Anthem Bio Sciences

Molecular Diagnostic Services, Inc

Invitrocue

TCG Lifesciences Private Limited

Q 2 Solutions

WuXi AppTec

oncodesign service

Alliance Pharma, Inc

QPS Holdings

NUVISAN

Drug Metabolism and Pharmacokinetics (DMPK) Service Segment by Type

In Vivo Drug Metabolism and Pharmacokinetics Services

In Vitro Drug Metabolism and Pharmacokinetics Services

Drug Metabolism and Pharmacokinetics (DMPK) Service Segment by Application

Pharmaceutical Research and Development

Biotechnology

Efficacy Testing

Others

Drug Metabolism and Pharmacokinetics (DMPK) Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Drug Metabolism and Pharmacokinetics (DMPK) Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Drug Metabolism and Pharmacokinetics (DMPK) Service key companies, revenue, market share, and recent developments.

3. To split the Drug Metabolism and Pharmacokinetics (DMPK) Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Drug Metabolism and Pharmacokinetics (DMPK) Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Drug Metabolism and Pharmacokinetics (DMPK) Service significant trends, drivers, influence factors in global and regions.

6. To analyze Drug Metabolism and Pharmacokinetics (DMPK) Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Metabolism and Pharmacokinetics (DMPK) Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Metabolism and Pharmacokinetics (DMPK) Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Metabolism and Pharmacokinetics (DMPK) Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drug Metabolism and Pharmacokinetics (DMPK) Service industry.

Chapter 3: Detailed analysis of Drug Metabolism and Pharmacokinetics (DMPK) Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Drug Metabolism and Pharmacokinetics (DMPK) Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Drug Metabolism and Pharmacokinetics (DMPK) Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Drug Metabolism and Pharmacokinetics (DMPK) Service Industry Trends Table 2. Drug Metabolism and Pharmacokinetics (DMPK) Service Industry Drivers Table 3. Drug Metabolism and Pharmacokinetics (DMPK) Service Industry Opportunities and Challenges Table 4. Drug Metabolism and Pharmacokinetics (DMPK) Service Industry Restraints Table 5. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue Share by Company (2021-2026) Table 7. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Key Company Manufacturing Base & Headquarters Table 9. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Company, Product Type & Application Table 10. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Drug Metabolism and Pharmacokinetics (DMPK) Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of In Vivo Drug Metabolism and Pharmacokinetics Services Table 15. Significant Companies of In Vitro Drug Metabolism and Pharmacokinetics Services Table 16. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type (2021-2026) Table 20. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Pharmaceutical Research and Development Table 22. Significant Companies of Biotechnology Table 23. Significant Companies of Efficacy Testing Table 24. Significant Companies of Others Table 25. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application (2021-2026) Table 29. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application (2027-2032) Table 30. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Region (2021-2026) Table 33. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Region (2027-2032) Table 35. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Market Share by Country (2021-2026) Table 38. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Market Share by Country (2027-2032) Table 40. NuChem Sciences Inc Company Information Table 41. NuChem Sciences Inc Business Overview Table 42. NuChem Sciences Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. NuChem Sciences Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 44. NuChem Sciences Inc Recent Development Table 45. Sygnature Discovery Company Information Table 46. Sygnature Discovery Business Overview Table 47. Sygnature Discovery Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Sygnature Discovery Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 49. Sygnature Discovery Recent Development Table 50. Paraza Pharma, Inc Company Information Table 51. Paraza Pharma, Inc Business Overview Table 52. Paraza Pharma, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Paraza Pharma, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 54. Paraza Pharma, Inc Recent Development Table 55. Dalriada Company Information Table 56. Dalriada Business Overview Table 57. Dalriada Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Dalriada Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 59. Dalriada Recent Development Table 60. Inotiv Company Information Table 61. Inotiv Business Overview Table 62. Inotiv Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Inotiv Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 64. Inotiv Recent Development Table 65. Eurofins Discovery Company Information Table 66. Eurofins Discovery Business Overview Table 67. Eurofins Discovery Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Eurofins Discovery Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 69. Eurofins Discovery Recent Development Table 70. RTI International Company Information Table 71. RTI International Business Overview Table 72. RTI International Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. RTI International Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 74. RTI International Recent Development Table 75. Frontage Labs Company Information Table 76. Frontage Labs Business Overview Table 77. Frontage Labs Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Frontage Labs Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 79. Frontage Labs Recent Development Table 80. Labcorp Company Information Table 81. Labcorp Business Overview Table 82. Labcorp Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Labcorp Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 84. Labcorp Recent Development Table 85. Jubilant Biosys Company Information Table 86. Jubilant Biosys Business Overview Table 87. Jubilant Biosys Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Jubilant Biosys Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 89. Jubilant Biosys Recent Development Table 90. Creative Biolabs Company Information Table 91. Creative Biolabs Business Overview Table 92. Creative Biolabs Drug Metabolism and Pharmacokinetics (DMPK) Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Creative Biolabs Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 94. Creative Biolabs Recent Development Table 95. Evotec Company Information Table 96. Evotec Business Overview Table 97. Evotec Drug Metabolism and Pharmacokinetics (DMPK) Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Evotec Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 99. Evotec Recent Development Table 100. Charles River Company Information Table 101. Charles River Business Overview Table 102. Charles River Drug Metabolism and Pharmacokinetics (DMPK) Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Charles River Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 104. Charles River Recent Development Table 105. Anthem Bio Sciences Company Information Table 106. Anthem Bio Sciences Business Overview Table 107. Anthem Bio Sciences Drug Metabolism and Pharmacokinetics (DMPK) Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Anthem Bio Sciences Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 109. Anthem Bio Sciences Recent Development Table 110. Molecular Diagnostic Services, Inc Company Information Table 111. Molecular Diagnostic Services, Inc Business Overview Table 112. Molecular Diagnostic Services, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Molecular Diagnostic Services, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 114. Molecular Diagnostic Services, Inc Recent Development Table 115. Invitrocue Company Information Table 116. Invitrocue Business Overview Table 117. Invitrocue Drug Metabolism and Pharmacokinetics (DMPK) Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Invitrocue Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 119. Invitrocue Recent Development Table 120. TCG Lifesciences Private Limited Company Information Table 121. TCG Lifesciences Private Limited Business Overview Table 122. TCG Lifesciences Private Limited Drug Metabolism and Pharmacokinetics (DMPK) Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. TCG Lifesciences Private Limited Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 124. TCG Lifesciences Private Limited Recent Development Table 125. Q 2 Solutions Company Information Table 126. Q 2 Solutions Business Overview Table 127. Q 2 Solutions Drug Metabolism and Pharmacokinetics (DMPK) Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Q 2 Solutions Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 129. Q 2 Solutions Recent Development Table 130. WuXi AppTec Company Information Table 131. WuXi AppTec Business Overview Table 132. WuXi AppTec Drug Metabolism and Pharmacokinetics (DMPK) Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. WuXi AppTec Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 134. WuXi AppTec Recent Development Table 135. oncodesign service Company Information Table 136. oncodesign service Business Overview Table 137. oncodesign service Drug Metabolism and Pharmacokinetics (DMPK) Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. oncodesign service Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 139. oncodesign service Recent Development Table 140. Alliance Pharma, Inc Company Information Table 141. Alliance Pharma, Inc Business Overview Table 142. Alliance Pharma, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. Alliance Pharma, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 144. Alliance Pharma, Inc Recent Development Table 145. QPS Holdings Company Information Table 146. QPS Holdings Business Overview Table 147. QPS Holdings Drug Metabolism and Pharmacokinetics (DMPK) Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 148. QPS Holdings Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 149. QPS Holdings Recent Development Table 150. NUVISAN Company Information Table 151. NUVISAN Business Overview Table 152. NUVISAN Drug Metabolism and Pharmacokinetics (DMPK) Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 153. NUVISAN Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 154. NUVISAN Recent Development Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Drug Metabolism and Pharmacokinetics (DMPK) Service Product Image Figure 2. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. In Vivo Drug Metabolism and Pharmacokinetics Services Image Figure 8. In Vitro Drug Metabolism and Pharmacokinetics Services Image Figure 9. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type (2021-2032) Figure 12. Pharmaceutical Research and Development Image Figure 13. Biotechnology Image Figure 14. Efficacy Testing Image Figure 15. Others Image Figure 16. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application (2021-2032) Figure 19. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value (2021-2032) & (US$ Million) Figure 22. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value (2021-2032) & (US$ Million) Figure 28. South America Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • In Vivo Drug Metabolism and Pharmacokinetics Services
  • In Vitro Drug Metabolism and Pharmacokinetics Services
Applications
  • Pharmaceutical Research and Development
  • Biotechnology
  • Efficacy Testing
  • Others
Companies covered
  • NuChem Sciences Inc
  • Sygnature Discovery
  • Paraza Pharma, Inc
  • Dalriada
  • Inotiv
  • Eurofins Discovery
  • RTI International
  • Frontage Labs
  • Labcorp
  • Jubilant Biosys
  • Creative Biolabs
  • Evotec
  • Charles River
  • Anthem Bio Sciences
  • Molecular Diagnostic Services, Inc
  • Invitrocue
  • TCG Lifesciences Private Limited
  • Q 2 Solutions
  • WuXi AppTec
  • oncodesign service
  • Alliance Pharma, Inc
  • QPS Holdings
  • NUVISAN

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Drug Metabolism and Pharmacokinetics (DMPK) Service Market Dynamics
  1. 2.1 Drug Metabolism and Pharmacokinetics (DMPK) Service Industry Trends
  2. 2.2 Drug Metabolism and Pharmacokinetics (DMPK) Service Industry Drivers
  3. 2.3 Drug Metabolism and Pharmacokinetics (DMPK) Service Industry Opportunities and Challenges
  4. 2.4 Drug Metabolism and Pharmacokinetics (DMPK) Service Industry Restraints
3 Drug Metabolism and Pharmacokinetics (DMPK) Service Market by Company
  1. 3.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Company Revenue Ranking in 2025
  2. 3.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue by Company (2021-2026)
  3. 3.3 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Company Ranking (2024-2026)
  4. 3.4 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Company Product Type and Application
  6. 3.6 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Drug Metabolism and Pharmacokinetics (DMPK) Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Drug Metabolism and Pharmacokinetics (DMPK) Service Market by Type
  1. 4.1 Drug Metabolism and Pharmacokinetics (DMPK) Service Type Introduction
  2. 4.1.1 In Vivo Drug Metabolism and Pharmacokinetics Services
  3. 4.1.2 In Vitro Drug Metabolism and Pharmacokinetics Services
  4. 4.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value by Type
  5. 4.2.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value by Type (2021-2032)
  7. 4.2.3 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type (2021-2032)
5 Drug Metabolism and Pharmacokinetics (DMPK) Service Market by Application
  1. 5.1 Drug Metabolism and Pharmacokinetics (DMPK) Service Application Introduction
  2. 5.1.1 Pharmaceutical Research and Development
  3. 5.1.2 Biotechnology
  4. 5.1.3 Efficacy Testing
  5. 5.1.4 Others
  6. 5.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value by Application
  7. 5.2.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value by Application (2021-2032)
  9. 5.2.3 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application (2021-2032)
6 Drug Metabolism and Pharmacokinetics (DMPK) Service Regional Value Analysis
  1. 6.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value (2021-2032)
  7. 6.3.2 North America Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value (2021-2032)
  10. 6.4.2 Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value (2021-2032)
  16. 6.6.2 South America Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Country, 2025 VS 2032
7 Drug Metabolism and Pharmacokinetics (DMPK) Service Country-level Value Analysis
  1. 7.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Drug Metabolism and Pharmacokinetics (DMPK) Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 NuChem Sciences Inc
  2. 8.1.1 NuChem Sciences Inc Company Information
  3. 8.1.2 NuChem Sciences Inc Business Overview
  4. 8.1.3 NuChem Sciences Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 NuChem Sciences Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  6. 8.1.5 NuChem Sciences Inc Recent Developments
  7. 8.2 Sygnature Discovery
  8. 8.2.1 Sygnature Discovery Company Information
  9. 8.2.2 Sygnature Discovery Business Overview
  10. 8.2.3 Sygnature Discovery Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sygnature Discovery Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  12. 8.2.5 Sygnature Discovery Recent Developments
  13. 8.3 Paraza Pharma, Inc
  14. 8.3.1 Paraza Pharma, Inc Company Information
  15. 8.3.2 Paraza Pharma, Inc Business Overview
  16. 8.3.3 Paraza Pharma, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Paraza Pharma, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  18. 8.3.5 Paraza Pharma, Inc Recent Developments
  19. 8.4 Dalriada
  20. 8.4.1 Dalriada Company Information
  21. 8.4.2 Dalriada Business Overview
  22. 8.4.3 Dalriada Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Dalriada Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  24. 8.4.5 Dalriada Recent Developments
  25. 8.5 Inotiv
  26. 8.5.1 Inotiv Company Information
  27. 8.5.2 Inotiv Business Overview
  28. 8.5.3 Inotiv Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Inotiv Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  30. 8.5.5 Inotiv Recent Developments
  31. 8.6 Eurofins Discovery
  32. 8.6.1 Eurofins Discovery Company Information
  33. 8.6.2 Eurofins Discovery Business Overview
  34. 8.6.3 Eurofins Discovery Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Eurofins Discovery Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  36. 8.6.5 Eurofins Discovery Recent Developments
  37. 8.7 RTI International
  38. 8.7.1 RTI International Company Information
  39. 8.7.2 RTI International Business Overview
  40. 8.7.3 RTI International Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 RTI International Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  42. 8.7.5 RTI International Recent Developments
  43. 8.8 Frontage Labs
  44. 8.8.1 Frontage Labs Company Information
  45. 8.8.2 Frontage Labs Business Overview
  46. 8.8.3 Frontage Labs Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Frontage Labs Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  48. 8.8.5 Frontage Labs Recent Developments
  49. 8.9 Labcorp
  50. 8.9.1 Labcorp Company Information
  51. 8.9.2 Labcorp Business Overview
  52. 8.9.3 Labcorp Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Labcorp Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  54. 8.9.5 Labcorp Recent Developments
  55. 8.10 Jubilant Biosys
  56. 8.10.1 Jubilant Biosys Company Information
  57. 8.10.2 Jubilant Biosys Business Overview
  58. 8.10.3 Jubilant Biosys Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Jubilant Biosys Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  60. 8.10.5 Jubilant Biosys Recent Developments
  61. 8.11 Creative Biolabs
  62. 8.11.1 Creative Biolabs Company Information
  63. 8.11.2 Creative Biolabs Business Overview
  64. 8.11.3 Creative Biolabs Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Creative Biolabs Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  66. 8.11.5 Creative Biolabs Recent Developments
  67. 8.12 Evotec
  68. 8.12.1 Evotec Company Information
  69. 8.12.2 Evotec Business Overview
  70. 8.12.3 Evotec Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Evotec Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  72. 8.12.5 Evotec Recent Developments
  73. 8.13 Charles River
  74. 8.13.1 Charles River Company Information
  75. 8.13.2 Charles River Business Overview
  76. 8.13.3 Charles River Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Charles River Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  78. 8.13.5 Charles River Recent Developments
  79. 8.14 Anthem Bio Sciences
  80. 8.14.1 Anthem Bio Sciences Company Information
  81. 8.14.2 Anthem Bio Sciences Business Overview
  82. 8.14.3 Anthem Bio Sciences Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Anthem Bio Sciences Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  84. 8.14.5 Anthem Bio Sciences Recent Developments
  85. 8.15 Molecular Diagnostic Services, Inc
  86. 8.15.1 Molecular Diagnostic Services, Inc Company Information
  87. 8.15.2 Molecular Diagnostic Services, Inc Business Overview
  88. 8.15.3 Molecular Diagnostic Services, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Molecular Diagnostic Services, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  90. 8.15.5 Molecular Diagnostic Services, Inc Recent Developments
  91. 8.16 Invitrocue
  92. 8.16.1 Invitrocue Company Information
  93. 8.16.2 Invitrocue Business Overview
  94. 8.16.3 Invitrocue Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Invitrocue Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  96. 8.16.5 Invitrocue Recent Developments
  97. 8.17 TCG Lifesciences Private Limited
  98. 8.17.1 TCG Lifesciences Private Limited Company Information
  99. 8.17.2 TCG Lifesciences Private Limited Business Overview
  100. 8.17.3 TCG Lifesciences Private Limited Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 TCG Lifesciences Private Limited Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  102. 8.17.5 TCG Lifesciences Private Limited Recent Developments
  103. 8.18 Q 2 Solutions
  104. 8.18.1 Q 2 Solutions Company Information
  105. 8.18.2 Q 2 Solutions Business Overview
  106. 8.18.3 Q 2 Solutions Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Q 2 Solutions Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  108. 8.18.5 Q 2 Solutions Recent Developments
  109. 8.19 WuXi AppTec
  110. 8.19.1 WuXi AppTec Company Information
  111. 8.19.2 WuXi AppTec Business Overview
  112. 8.19.3 WuXi AppTec Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue and Gross Margin (2021-2026)
  113. 8.19.4 WuXi AppTec Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  114. 8.19.5 WuXi AppTec Recent Developments
  115. 8.20 oncodesign service
  116. 8.20.1 oncodesign service Company Information
  117. 8.20.2 oncodesign service Business Overview
  118. 8.20.3 oncodesign service Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue and Gross Margin (2021-2026)
  119. 8.20.4 oncodesign service Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  120. 8.20.5 oncodesign service Recent Developments
  121. 8.21 Alliance Pharma, Inc
  122. 8.21.1 Alliance Pharma, Inc Company Information
  123. 8.21.2 Alliance Pharma, Inc Business Overview
  124. 8.21.3 Alliance Pharma, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Alliance Pharma, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  126. 8.21.5 Alliance Pharma, Inc Recent Developments
  127. 8.22 QPS Holdings
  128. 8.22.1 QPS Holdings Company Information
  129. 8.22.2 QPS Holdings Business Overview
  130. 8.22.3 QPS Holdings Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue and Gross Margin (2021-2026)
  131. 8.22.4 QPS Holdings Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  132. 8.22.5 QPS Holdings Recent Developments
  133. 8.23 NUVISAN
  134. 8.23.1 NUVISAN Company Information
  135. 8.23.2 NUVISAN Business Overview
  136. 8.23.3 NUVISAN Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue and Gross Margin (2021-2026)
  137. 8.23.4 NUVISAN Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  138. 8.23.5 NUVISAN Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst